Novel markers of MCL1 inhibitor sensitivity in triple negative breast cancer cells. Duan L, Tadi MJ, O'Hara KM, Maki CG, et al. J Biol Chem 2024 May 16:107375. doi: 10.1016/j.jbc.2024.107375.

Read + Share

Amedeo Smart

Independent Medical Education

Duan L, Tadi MJ, O'Hara KM, Maki CG, et al. Novel markers of MCL1 inhibitor sensitivity in triple negative breast cancer cells. J Biol Chem 2024 May 16:107375. doi: 10.1016/j.jbc.2024.107375.
PMID: 38762181